Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Country / region: Israel Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20121
20151
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Cardurion Pharmaceuticals, Inc.1
Celladon Corporation1
Enopace Biomedical1
KAI Pharmaceuticals1
Novartis Pharmaceuticals1
Rabin Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases7
Heart Diseases4
Heart Failure3
Acquired Immunodeficiency Syndrome1
Atherosclerosis1
Cardiomegaly1
Cardiomyopathies1
Diabetes Mellitus, Type 21
Embolism1
Embolism and Thrombosis1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.